A phase I clinical trial of MDNA19
Latest Information Update: 20 May 2020
At a glance
- Drugs MDNA 19 (Primary)
- Indications Cancer
- Focus Adverse reactions
Most Recent Events
- 15 May 2020 According to a Medicenna Therapeutics media release, the company plans Initiation of Phase 1 clinical study for MDNA109 Superkine Platform (MDNA19 or MDNA11) in mid-2021.
- 17 Mar 2020 According to a Medicenna Therapeutics media release, the company expects to initiate this monotherapy trial next year.
- 30 Aug 2019 New trial record